TEL AVIV, Israel and PLANO, Texas , Sept. 21, 2017 -- Top Image Systems, Ltd. (NASDAQ:TISA), a global provider of solutions that facilitate digital business, today announced that its 2017 Annual Meeting of the Shareholders will be held at the Company’s offices at 1 B.S.R. Tower, 2 Ben Gurion St., Ramat Gan, on October 19, 2017, at 10 a.m. (Israeli time). TIS’ Shareholders of record at the close of business on September 5, 2017, will be entitled to receive notice of, and to vote at, the Meeting and any adjournments thereof.
The notice and proxy statement are available at: https://www.topimagesystems.com/community/investors/investor-documents/
About Top Image Systems
Top Image Systems™ (TIS™) Ltd. is a global innovator of on-premise and cloud-based applications that optimize content-driven business processes such as procure to pay operations, remittance processing, integrated receivables, customer response management and more. Whether originating from mobile, electronic, paper or other sources, TIS solutions automatically capture, process and deliver content across enterprise applications, transforming information entering an organization into useful and accessible electronic data, delivering it directly and efficiently to the relevant business system or person for action with as little manual handling as possible. TIS’ solutions are marketed in more than 40 countries through a multi-tier network of distributors, system integrators, value-added resellers and strategic partners. Visit the company's website at https://www.topimagesystems.com/for more information.
TIS Company Contact
Camille Womack
Director of Corporate Marketing and Investor Relations
[email protected]
(214) 256-4600
Investors:
James Carbonara
Regional Vice President, Hayden IR
[email protected]
+1 646 755 7412
Top Image Systems Caution Concerning Forward-Looking Statements
Certain matters discussed in this news release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results to be materially different from any future results expressed or implied in those forward looking statements. Words such as "will," "expects,", "anticipates," "estimates," and words and terms of similar substance in connection with any discussion of future operating or financial performance identify forward-looking statements. These statements are based on management's current expectations or beliefs and are subject to a number of risks and uncertainties that could cause actual results to differ materially including, but not limited to, risks in product development, approval and introduction plans and schedules, rapid technological change, customer acceptance of new products, the impact of competitive products and pricing, the lengthy sales cycle, proprietary rights of TIS and its competitors, risk of operations in Israel, government regulation, litigation, general economic conditions and other risk factors detailed in the Company's most recent annual report on Form 20-F and other subsequent filings with the United States Securities and Exchange Commission. We are under no obligation to, and expressly disclaim any obligation to, update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.


John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Italy Fines Apple €98.6 Million Over App Store Dominance
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Nvidia and Groq Strike Strategic AI Inference Licensing Deal
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage 



